mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |
mRNA |
BRD6340 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0004 |
mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0006 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0006 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.0006 |
mRNA |
Repligen 136 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0006 |
mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0006 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0006 |
mRNA |
SB-525334 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0007 |